A malaria vaccine is becoming ordinary childhood care.
A public-health breakthrough becomes more consequential when clinics can deliver it routinely.
Good outcome probability
At least 25 countries in Africa will still offer malaria vaccines through childhood programmes at the end of 2026.
Medical progress becomes a social achievement only when it can be delivered. Two malaria vaccines have moved into national strategies that once had no vaccine option at all.
WHO identifies vaccination as one part of malaria prevention, alongside insecticide-treated nets, diagnosis and treatment. It does not promise that a vaccinated child cannot become infected.
The consequential policy choice is reliable support for local delivery. Clinics need staff, supply chains and public confidence just as urgently as new scientific discoveries.
What this could mean.
- Why this could be good
- Protecting children from malaria can prevent severe disease and reduce reliance on emergency treatment.
- Potential positive outcomes
More children could survive the most dangerous stages of a malaria infection.
Routine vaccine visits could increase opportunities for other preventive care.
Unreliable financing could make access uneven between regions.
The assessment.
- What we are forecasting
- At least 25 countries in Africa will still offer malaria vaccines through childhood programmes at the end of 2026.
- Time horizon
- Through December 2027
- Editorial confidence in the evidence: 94%
- WHO reported 25 countries already offering malaria vaccines by early 2026.
- What could change the outcome
- Budget disruption or conflict could interrupt rollout in some countries.
The evidence.
- Malaria vaccines: questions and answers ↗World Health Organization · February 2026